SFM
RVMD icon

Sphera Funds Management’s Revolution Medicines RVMD Stock Holding History

Sphera Funds Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.2M Sell
22,400
-32,710
-59% -$4.78M 0.55% 64
2026
Q1 		$5.36M Buy
55,110
+2,610
+5% +$264K 0.85% 44
2025
Q4 		$4.18M Sell
52,500
-7,500
-13% -$492K 0.81% 50
2025
Q3 		$2.8M Buy
+60,000
New +$2.35M 0.59% 58

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Sphera Funds Management's RVMD Position: Q2 2026 in Review

Sphera Funds Management reduced its Revolution Medicines (RVMD) stake by 59% in Q2 2026, selling an estimated $4.78M and leaving 22,400 shares worth $4.2M. The position accounts for 0.55% of the portfolio, ranked #64.

Sphera Funds Management first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.36M in Q1 2026. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Sphera Funds Management held 22,400 shares of Revolution Medicines worth $4.2M as of Q2 2026.
  • Sphera Funds Management sold 32,710 Revolution Medicines shares in Q2 2026, an estimated $4.78M.
  • Revolution Medicines made up 0.55% of Sphera Funds Management's portfolio in Q2 2026, its #64 holding.
  • Sphera Funds Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • Sphera Funds Management's Revolution Medicines position peaked at $5.36M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.